Donation to the Ophthalmic Community

The Company has formulated Donation Rules, to clarify the basic policy on donation in accordance with CORE PRINCIPLE and the procedure to be followed in making donations, and to continuously make social contribution as a corporate citizen.

The Company donates to research institutions including universities, academic societies, and research groups of specialists, mainly in fields related to the "eyes," with the aim of contributing to the development of medicine and pharmacology and to health care. Santen also donates continually to the promotion of corneal transplantation, activities to prevent eyesight loss in developing countries conducted by health care professionals and NGOs in and outside Japan, activities to support the self-reliance of the visually impaired, and disease awareness campaigns conducted by ophthalmic societies and public-interest incorporated foundations. In addition to those, Santen continually donates pharmaceuticals and medical devices such as intraocular lenses for groups which conduct ophthalmic care activities in developing countries.

As a corporate citizen, the Company also contributes to disaster assistance and local community activities. The donations and contributions made by Santen Group in FY2023 reached 796 million yen, which is equivalent to 1.3% of consolidated core operating profits.

The Company supports organizations tackling activities to prevent vision loss. We annually donate to and support the activities of: the Japan National Society for the Prevention of Blindness, which engages in blindness-prevention activities in Japan; and the Japan Eye Bank Association, which promotes corneal transplantation.

The Company donates pharmaceuticals and medical devices such as intraocular lenses for groups which conduct ophthalmic care activities in developing countries.
In donating products, we ensure compliance with WHO guidelines for drug donations, relevant national and regional laws and regulations, and industry self-imposed regulations.

To reduce as much risk of the COVID-19 infection as possible during ophthalmology practice, we created a total of 60,000 anti-droplet infection shields to be attached to slit lamps(*) used in ophthalmology practices, and provided them to ophthalmology Institutions worldwide such as in Japan, EMEA, China, Asia, and U.S. in FY2020.

We aim to continue contributing to ophthalmic medical care, including such activities.